Recently, according to report, on December 20, 2024, Park Ha Biological Technology Co., Ltd. (hereinafter referred to as “Park Ha”), based in Wuxi, Jiangsu, updated its IPO prospectus with the U.S. Securities and Exchange Commission (SEC). The company’s stock ticker is “PHH,” and it plans to go public on the NASDAQ in the United States. Park Ha initially filed confidentially with the SEC on December 29, 2023, and later publicly disclosed its prospectus on August 26, 2024.
It is reported that Park Ha received an overseas listing filing notice from the International Cooperation Department of the China Securities Regulatory Commission (CSRC) on June 1, 2024. The company intends to issue no more than 2.3 million ordinary shares and list on the NASDAQ. If the IPO succeeds, Park Ha will become the first publicly listed company in the “single-brand skin management store” category.
Park Ha, headquartered in Wuxi, Jiangsu, is a professional skin management service provider focusing on delivering specialized skincare solutions for high-quality women. The company customizes exclusive skin management plans based on subtle differences in individual skin types.
Park Ha’s business primarily includes developing its proprietary skincare brand, directly selling skincare products, and promoting franchise alliances. As of April 30, 2024, the company directly operates two stores in Jiangsu, has 43 franchisees, and collaborates with two additional franchise operators (Geni).
The company’s revenue primarily consists of product sales and franchise fees. For the six months ending April 30, 2024, product sales accounted for 35% of total revenue, while franchise fees made up 65%. During the same period, the company generated revenue of $852,900. However, net income decreased from $499,796 as of April 30, 2023, to $48,900, a decline of $450,896 or 90.22%.
